Vraylar 1.5 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FE198
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,420
Award facts
- Contract value 100% obligated
- $26,420.11 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Vraylar 1.5 mg capsules (30-count) with a contract ceiling value of $26,420.11. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of December 4, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive pharmaceutical supply vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor specializing in medical procurement for military and veteran healthcare systems. The company's extensive contract portfolio with the DLA encompasses a broad range of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. All reviewed contract awards have been competitively awarded with firm fixed pricing, demonstrating the company's capability to meet federal procurement requirements. The DLA plans to establish multiple awards under its Pharmaceutical Prime Vendor Global Program Generation V contracts, with AmerisourceBergen positioned to serve customers including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DR26FE198?
SPE2DR26FE198 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26FE198 worth?
The government has obligated $26,420 on SPE2DR26FE198.
Is contract SPE2DR26FE198 an order under another contract?
Yes. SPE2DR26FE198 is a delivery order under SPE2DR25D1103, an indefinite delivery contract.
Was contract SPE2DR26FE198 competed?
The extent of competition for SPE2DR26FE198 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award